{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:29:25Z","timestamp":1761128965701},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jbspin.2011.09.015","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T04:28:43Z","timestamp":1322886523000},"page":"219-227","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic approach to giant cell arteritis"],"prefix":"10.1016","volume":"79","author":[{"given":"Charles","family":"Masson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2011.09.015_bib0005","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jbspin.2007.09.008","article-title":"Epidemiology, imaging, and treatment of giant cell arteritis","volume":"75","author":"Devauchelle-Pensec","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1755-3768.2008.01314.x","article-title":"Giant cell arteritis: an updated review","volume":"87","author":"Kawasaki","year":"2009","journal-title":"Acta Ophtalmologica"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2010.05.017","article-title":"Rheumatoid anemia","volume":"78","author":"Masson","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jbspin.2006.09.005","article-title":"Polymyalgia rheumatica: diagnosis and treatment","volume":"73","author":"Soubrier","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.monrhu.2010.01.005","article-title":"Pseudopolyarthrite rhizom\u00e9lique, MH. Crit\u00e8res de diagnostic et de suivi","volume":"77","author":"Masson","year":"2010","journal-title":"Rev Rhum Monographies"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/41.1.46","article-title":"Incidence of temporal arteritis in patients with polymyalgia rheumatica: a prospective study using colour Doppler ultrasonography of the temporal arteries","volume":"41","author":"Schmidt","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","article-title":"Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis","volume":"47","author":"Schmidt","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/rheumatology\/ken515","article-title":"Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?","volume":"48","author":"Schmidt","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2474-11-44","article-title":"The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis","volume":"11","author":"Arida","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophtalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0065","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/art.21226","article-title":"Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging","volume":"52","author":"Bley","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-Fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"18F-Fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockkmans","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0080","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.084947","article-title":"Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss","volume":"68","author":"Chatelain","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0085","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/art.30374","article-title":"Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis","volume":"63","author":"Ciccia","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0090","first-page":"141","article-title":"Occurrence of giant cell arteritis \u2026 suddenly","volume":"105","author":"Younge","year":"2007","journal-title":"Trans Am Ophtalmol Soc"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0095","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/keq039a","article-title":"BSR and BHPR guidelines for the management of giant cell arteritis","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0100","first-page":"140","article-title":"The treatment of giant cell arteritis","volume":"5","author":"Fraser","year":"2008","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0105","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0115","first-page":"1272","article-title":"Silent or masked giant cell arteritis is associated with a strong inflammatory response and a benign short term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0120","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/01.CIR.0000066907.83923.32","article-title":"Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism","volume":"107","author":"Hernandez-Rodriguez","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2007.10.014","article-title":"The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis","volume":"38","author":"Lopez-Diaz","year":"2008","journal-title":"Sem Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic comlications in giant cell arteritis","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/01658100802716754","article-title":"Giant cell arteritis: oral versus intravenous corticosteroids","volume":"33","author":"Tehrani","year":"2009","journal-title":"Neuro-Ophtalmol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0140","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids. A double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.23338","article-title":"Performance of the polymyalgia rheumatica activity score for diagnosing disease flares","volume":"59","author":"Binard","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kem283","article-title":"Mural inflammatory hyperenhancement in MRI of giant cell (temporal) arteritis resolves under corticosteroid treatment","volume":"47","author":"Bley","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0155","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4065\/79.4.483","article-title":"Initiation of glucocorticoid therapy: before or after temporal artery biopsy?","volume":"79","author":"Younge","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis. A population-based study of patients with biopsy-proven disease from Northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MD.0b013e318145275c","article-title":"Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica. Study of a series of 100 patients","volume":"86","author":"Hernandez-Rodriguez","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MD.0b013e318206af16","article-title":"Long-term follow-up of upper and lower extremity vasculitis related to giant cell arteritis. A series of 36 patients","volume":"90","author":"Assie","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0180","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.146910","article-title":"High white blood cell count in patients with giant cell arteritis predicts an increased risk of stenosis in upper extremity arteries","author":"Both","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0185","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jbspin.2009.05.005","article-title":"Vasculitis working group: selected unanswered questions related to giant cell arteritis and anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"76","author":"Yterberg","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0190","first-page":"1407","article-title":"Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases","volume":"28","author":"Le Hello","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200301000-00001","article-title":"Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature","volume":"82","author":"R\u00fcegg","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0205","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1002\/art.11480","article-title":"Mortality of large-artery complication (aortic aneuvrysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis. A population-based study over 50 years","volume":"48","author":"Nuenninghoff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneuvrysm and dissection in patients with biopsy-proven giant cell arteritis from Northwestern Spain. A population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/00313020600820898","article-title":"Review of isolated ascending aortitis: differential diagnosis, including syphilitic, Takayasu's and giant cell aortitis","volume":"38","author":"Tavora","year":"2006","journal-title":"Pathology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0220","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.humpath.2007.08.018","article-title":"Aortitis and ascending aortic aneuvrysm: description of 52 cases and proposal of a histological classification","volume":"39","author":"Burke","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0225","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.23577","article-title":"Aortic involvement in recent-onset giant cell (temporal) arteritis: a case control prospective study using helical aortic computed tomodensitometric scan","volume":"59","author":"Agard","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0230","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jbspin.2010.09.013","article-title":"Aortic involvement in giant cell arteritis: current data","volume":"78","author":"Bossert","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MD.0b013e318207231e","article-title":"Vasculitis of the gastrointestinal tract in chronic periaortitis","volume":"90","author":"Salvarini","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0240","unstructured":"Palazzi C, Salvarini C, D\u2019Angelo S, et al. Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine 2011;78:451\u20135, doi: 10.1016\/j.bspin2010.11.003."},{"key":"10.1016\/j.jbspin.2011.09.015_bib0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art1.10161","article-title":"A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis","volume":"47","author":"Hernandez-Rodriguez","year":"2002","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","article-title":"Prednisone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis","volume":"30","author":"Myklebust","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0255","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.lpm.2006.11.014","article-title":"Que reste-t-il de l\u2019insuffisance surr\u00e9nale post-MH\u00a0?","volume":"36","author":"Goichot","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0260","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.2005.042770","article-title":"Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better?","volume":"65","author":"Mahr","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0265","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A","article-title":"Temporal artery biopsy. A diagnostic tool for systemic necrotizing vasculitis","volume":"42","author":"Genereau","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0270","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/acr.20457","article-title":"Thromboangiitis involving the temporal artery","volume":"63","author":"Prokesch","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0275","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0280","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0285","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarini","year":"2005","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.revmed.2010.12.014","article-title":"Hallucinations visuelles et maladies de Horton\u00a0: \u00e0 propos du syndrome de Charles Bonnet","author":"Bloch","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0295","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.27429","article-title":"Cancer preceding giant cell arteritis. A case-control study","volume":"62","author":"Kermani","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/acr.20062","article-title":"Malignancy risk in patients with giant cell arteritis: a population-based cohort study","volume":"62","author":"Kermani","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0305","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid thrapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0310","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7","article-title":"Treatment of giant cell arteritis. Interleukin-6 as a biologic marker of disease activity","volume":"43","author":"Weyand","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0315","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive methotrexate for treatment of giant cell arteritis. An individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0320","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1297-319X(11)70001-X","article-title":"TNFalpha antagonist therapy and safety monitoring","volume":"78","author":"Pham","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0325","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Martinez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0330","doi-asserted-by":"crossref","first-page":"R176","DOI":"10.1186\/ar3140","article-title":"Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial","volume":"12","author":"Kreiner","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jbspin.2006.10.005","article-title":"Giant cell arteritis during adalimumab treatment for rheumatoid arthritis","volume":"74","author":"Leydet-Quilici","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0340","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/ar3269","article-title":"Response to effect of etanercept in polymyalgia rheumatica: a randomized controlled trial","volume":"13","author":"Watson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0345","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2010.149351","article-title":"Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0350","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0355","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1297-319X(10)70001-4","article-title":"Tocilizumab therapy and safety management","volume":"77","author":"Pham","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0360","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","article-title":"Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls","volume":"40","author":"Gran","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0365","first-page":"502","article-title":"Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0370","unstructured":"Crow RW, Katz BJ, Warner JEA, et al. Giant cell arteritis and mortality. J Gerontol 2007."},{"key":"10.1016\/j.jbspin.2011.09.015_bib0375","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/gerona\/gln030","article-title":"Giant cell arteritis and mortality","volume":"64A","author":"Wade Crow","year":"2009","journal-title":"J Gerontol"},{"key":"10.1016\/j.jbspin.2011.09.015_bib0380","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T06:25:14Z","timestamp":1713162314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X11002387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1297319X11002387"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2011.09.015","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}